Target & Activity
| Target | Activity | Value |
|---|---|---|
| HDAC1 (Cell-free assay) | 0.9 μM | |
| HDAC2 | 0.9 μM | |
| HDAC3 | 1.2 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A-375 | IC50 | 11.29 μM | Antiproliferative activity against human A375 cells assessed as reduction in cell growth incubated for 72 hrs by CCK-8 assay | [PMID: 31003060] |
| A-375 | IC50 | 11.29 μM | Antiproliferative activity against human A375 cells after 72 hrs by CCK-8 assay | [PMID: 29202397] |
| A-375 | IC50 | 11.3 μM | Antiproliferative activity against human A375 cells after 72 hrs CCK8 assay | [PMID: 30108928] |
| A-375 | IC50 | 9.64 μM | Antiproliferative activity against human A375 cells assessed as decrease in cell viability after 72 hrs by CCK-8 assay | [PMID: 31103900] |
| A549 | IC50 | 10.17 μM | Antiproliferative activity against human A549 cells after 72 hrs by CCK8 assay | [PMID: 30045621] |
| A549 | IC50 | 15.96 μM | Cytotoxicity against human A549 cells assessed as decrease in cell viability measured after 72 hrs by CellTiter-Glo Luminescent assay | [PMID: 31223439] |
| A549 | IC50 | 16.45 μM | Antiproliferative activity against human A549 cells assessed as decrease in cell viability after 72 hrs by CCK-8 assay | [PMID: 31103900] |
| A549 | IC50 | 20.1 μM | Antiproliferative activity against human A549 cells assessed as reduction in cell growth incubated for 72 hrs by CCK-8 assay | [PMID: 31003060] |
| A549 | IC50 | 20.1 μM | Antiproliferative activity against human A549 cells after 72 hrs by CCK-8 reagent based assay | [PMID: 28391133] |
| A549 | IC50 | 20.1 μM | Antiproliferative activity against human A549 cells after 72 hrs CCK8 assay | [PMID: 30108928] |
| Epithelial cell | IC50 | > 50 μM | Cytotoxicity against human mammary epithelial cells by MTT assay | [PMID: 17941625] |
| HCT-116 | IC50 | 10 μM | Cytotoxicity in human HCT116 cells assessed as reduction in cell viability after 72 hrs by MTT assay | [PMID: 28885834] |
| HCT-116 | IC50 | 4 μM | Cytotoxicity against human HCT116 cells by MTT assay | [PMID: 17941625] |
| HCT-116 | IC50 | 6.39 μM | Antiproliferative activity against human HCT116 cells assessed as decrease in cell viability after 72 hrs by CCK-8 assay | [PMID: 31103900] |
| HCT-116 | IC50 | 7.71 μM | Antiproliferative activity against human HCT116 cells assessed as reduction in cell growth incubated for 72 hrs by CCK-8 assay | [PMID: 31003060] |
| HCT-116 | IC50 | 7.71 μM | Antiproliferative activity against human HCT116 cells after 72 hrs by CCK-8 assay | [PMID: 29202397] |
| HCT-116 | IC50 | 7.71 μM | Antiproliferative activity against human HCT116 cells after 72 hrs by CCK-8 reagent based assay | [PMID: 28391133] |
| HCT-116 | EC50 | 8.4 μM | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability measured after 48 hrs by cell-titer glo assay | [PMID: 35293758] |
| HCT-116 | IC50 | 9.83 μM | Antiproliferative activity against human HCT116 cells after 72 hrs by CCK8 assay | [PMID: 30045621] |
| HeLa | IC50 | 1.81 μM | Inhibition of HDAC in human HeLa cell nuclear extract assessed as decrease in deacetylation of FLUOR DE LYS Green substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins by fluorescence based assay | [PMID: 31103900] |
20 records · Scroll to view more